Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate

Colloids and Surfaces B: Biointerfaces

Volumn 92, Issue , 2012, Pages 55-63

  Cheow, Wean Sin ^a   Hadinoto, Kunn ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Amphiphiles; Antibiotic; Dextran; Nanoparticles; Polyelectrolyte complexation; Self assembly

Indexed keywords

ANTI-BIOFILM; ANTI-MICROBIAL ACTIVITY; AQUEOUS SALT SOLUTION; BIOFILM INFECTIONS; CHARGE RATIO; COMPLEXATION PROCESS; CONTROLLED DRUG RELEASE; DEXTRAN SULFATES; DRUG LOADING; DRUG NANOPARTICLES; DRY POWDERS; FUNCTIONALIZATIONS; LEVOFLOXACIN; NANO SCALE; OFLOXACIN; POLYELECTROLYTE COMPLEXATION; PREPARATION CONDITIONS; SALT CONCENTRATION; SOLVENT FREE; TARGETED DELIVERY;

AMPHIPHILES; BIOFILMS; CONTROLLED DRUG DELIVERY; DEXTRAN; DRUG DOSAGE; GLASS TRANSITION; LOADING; NANOPARTICLES; PH EFFECTS; POLYELECTROLYTES; SELF ASSEMBLY;

ANTIBIOTICS;

DEXTRAN SULFATE; LEVOFLOXACIN; NANOPARTICLE; OFLOXACIN; POLYELECTROLYTE;

AMPHOPHILICITY; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CHEMICAL PHENOMENA; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG LOADING; DRUG SOLUBILITY; DRUG STABILITY; DRUG TO POLYELECTROLYTE CHARGE RATIO; GREEN CHEMISTRY; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PH; PHARMACOLOGICAL PARAMETERS; POWDER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SELF ASSEMBLY AMPHIPHILE POLYELECTROLYTE COMPLEXATION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOFILMS; CALORIMETRY, DIFFERENTIAL SCANNING; DEXTRAN SULFATE; ELECTROLYTES; GREEN CHEMISTRY TECHNOLOGY; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; OFLOXACIN; PARTICLE SIZE; POWDERS; PSEUDOMONAS AERUGINOSA; SODIUM CHLORIDE; SURFACE-ACTIVE AGENTS; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 84856102432     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.11.024     Document Type: Article

References (24)

1. Meers P., Neville M., Malinin V., Scotto A.W., Sardaryan G., Kurumunda R., Mackinson C., James G., Fisher S., Perkins W.R. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemother. 2008, 61:859-868.
2. Suk J.S., Lai S.K., Wang Y.Y., Ensign L.M., Zeitlin P.L., Boyle M.P., Hanes J. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 2009, 30:2591-2597.
3. Alipour M., Suntres Z.E., Lafrenie R.M., Omri A. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. J. Antimicrob. Chemother. 2010, 65:684-693.
4. Cheow W.S., Chang M.W., Hadinoto K. Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm. Res. 2010, 27:1597-1609.
5. Rogueda P.G.A., Traini D. The nanoscale in pulmonary delivery. Part 1. Deposition, fate, toxicology and effects. Expert Opin. Drug Deliv. 2007, 4:595-606.
6. Sanders N.N., De Smedt S.C., Van Rompaey E., Simoens P., De Baets F., Demeester J. Cystic fibrosis sputum - a barrier to the transport of nanospheres. Am. J. Resp. Crit. Care 2000, 162:1905-1911.
7. Cheow W.S., Hadinoto K. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf. B: Biointerfaces 2011, 85:214-220.
8. Pauwels R.A., Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004, 364:613-620.
9. Schartl W. Current directions in core-shell nanoparticle design. Nanoscale 2010, 2:829-843.
10. Lvov Y.M., Pattekari P., Zhang X.C., Torchilin V. Converting poorly soluble materials into stable aqueous nanocolloids. Langmuir 2011, 27:1212-1217.
11. Zheng Z.G., Zhang X.C., Carbo D., Clark C., Nathan C.A., Lvov Y. Sonication-assisted synthesis of polyelectrolyte-coated curcumin nanoparticles. Langmuir 2010, 26:7679-7681.
12. Shegokar R., Muller R.H. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int. J. Pharm. 2010, 399:129-139.
13. Peltonen L., Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J. Pharm. Pharmacol. 2010, 62:1569-1579.
14. Rogers T.L., Gillespie I.B., Hitt J.E., Fransen K.L., Crowl C.A., Tucker C.J., Kupperblatt G.B., Becker J.N., Wilson D.L., Todd C., Elder E.J. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs. Pharm. Res. 2004, 21:2048-2057.
15. Van Bambeke F., Balzi E., Tulkens P.M. Antibiotic efflux pumps - commentary. Biochem. Pharmacol. 2000, 60:457-470.
16. Bain C.D., Claesson P.M., Langevin D., Meszaros R., Nylander T., Stubenrauch C., Titmuss S., von Klitzing R. Complexes of surfactants with oppositely charged polymers at surfaces and in bulk. Adv. Colloid Interface Sci 2010, 155:32-49.
17. Caram-Lelham N., Hed F., Sundelöf L.-O. Adsorption of charged amphiphiles to oppositely charged polysaccharides - a study of the influence of polysaccharide structure and hydrophobicity of the amphiphile molecule. Biopolymers 1997, 41:765-772.
18. Hugerth A., Sundelöf L.-O. The effect of polyelectrolyte counterion specificity, charge density, and conformation on polyelectrolyte-amphiphile interaction: the carrageenan/furcellaran-amitriptyline system. Biopolymers 2001, 58:186-194.
19. Sun W., Mao S.R., Mei D., Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin. Eur. J. Pharm. Biopharm. 2008, 69:417-425.
20. Ranjan A., Pothayee N., Seleem M., Jain N., Sriranganathan N., Riffle J.S., Kasimanickam R. Drug delivery using novel nanoplexes against a Salmonella mouse infection model. J. Nanopart. Res. 2010, 12:905-914.
21. Singh S.K., Caram-Lelham N. Thermodynamics of kappa-carrageenan-amphiphilic drug interaction as influenced by specific counterions and temperature: a microcalorimetric and viscometric study. J. Colloid Interface Sci. 1998, 203:430-446.
22. Piddock L.J.V., Ricci V. Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv. J. Antimicrob. Chemother. 2001, 48:787-791.
23. Zhou C.C., Qi X.B., Li P., Chen W.N., Mouad L., Chang M.W., Leong S.S.J., Chan-Park M.B. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides. Biomacromolecules 2010, 11:60-67.
24. Goyne K.W., Chorover J., Kubicki J.D., Zimmerman A.R., Brantley S.L. Sorption of the antibiotic ofloxacin to mesoporous and nonporous alumina and silica. J. Colloid Interface Sci. 2005, 283:160-170.